Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- Check5 days agoChange Detected- A new funding attribution line '2018 ( U.S. NIH Grant/Contract )' was added to the study identifiers section. This indicates NIH support for the trial.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4. This reflects a deployment update and does not alter the study information presented.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page's revision label changed from v3.6.3 to v3.6.4, representing a small, non-substantive update to the page version.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision label updated from Revision: v3.6.0 to Revision: v3.6.3, indicating a backend or UI update rather than a change to the study details.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded the study's responsible party name (Luis F. Lopez-Cortes) and status indicators (Last verified; Last known status was), along with new navigation links (How to Read a Study Record, Common Questions, How to Join a Study) and a standardized Intervention/Treatment label with a revision update to v3.6.0. The previous items and formatting (Last known status was; Verified; Luis F. Lopez-Cortes; Hospitales Universitarios Virgen del Rocío; Intervention / Treatment; Revision: v3.5.5) were removed or reformatted.SummaryDifference2%

- Check84 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor page/configuration update.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.